相关实验视频
Updated: Jan 8, 2026

09:42
Comprehensive Analysis of Drug Response using the FLICK Assay
Published on: June 6, 2025
671
对菲尔戈提尼布的FDA不良事件报告系统 (FAERS) 事件的不成比例分析
Yinli Shi1, Shuang Guan1, Sicun Wang1
1Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
PloS one
|December 15, 2025
概括
这项研究分析了2014-2024年间的菲尔戈提尼布不良事件,确定了感染和胃肠道问题等常见问题. 它强调了诸如心房动和肌水平升高等特定风险,强调了需要仔细监测患者的必要性.
科学领域:
- 药物监督和药物安全研究.
- 对雅努斯酶 (JAK) 抑制剂的安全概况进行分析.
- 炎症疾病治疗的临床药理学.
背景情况:
- 菲尔戈提尼布是一种选择性的Janus激酶1抑制剂,用于炎症性疾病.
- 它的全面安全概况需要进一步描述.
- 了解药物不良事件 (ADEs) 对于安全的临床使用至关重要.
研究的目的:
- 为了分析与filgotinib相关的不良事件信号.
- 为菲尔戈提尼布安全有效的临床应用提供指导.
- 为了描述菲尔戈提尼布的综合安全概况.
主要方法:
- 从2014年第一季度到2024年第二季度,FAERS数据库的数据挖掘.
- 使用信号检测方法,包括ROR,PRR,BCPNN和MGPS.
- 标准化数据用于强大的药物不良事件分析.
主要成果:
- 菲尔戈提尼布是17个器官系统类别中的103个首选术语中的主要疑似药物.
- 常见的不良事件包括感染,胃肠道和肌肉骨系统疾病.
- 确定了心房动,肌水平升高,肺栓塞和其他未在药物标签上列出的潜在信号,显著发现大肠侵蚀和中腔动脉封闭.
结论:
- 菲尔戈提尼布表现出治疗效益,但具有潜在的不良事件.
- 警的临床监测对于服用菲尔戈提尼布的患者至关重要.
- 应特别注意胃肠道,心血管,呼吸道和代谢并发症.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
FDA Approved Drugs: Changes to Approved Drugs
227
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
227
Bioequivalence studies: Biowaivers
206
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
206
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175

